AU2021376350A1 - Precise genome deletion and replacement method based on prime editing - Google Patents

Precise genome deletion and replacement method based on prime editing Download PDF

Info

Publication number
AU2021376350A1
AU2021376350A1 AU2021376350A AU2021376350A AU2021376350A1 AU 2021376350 A1 AU2021376350 A1 AU 2021376350A1 AU 2021376350 A AU2021376350 A AU 2021376350A AU 2021376350 A AU2021376350 A AU 2021376350A AU 2021376350 A1 AU2021376350 A1 AU 2021376350A1
Authority
AU
Australia
Prior art keywords
domain
sequence
editing
dsdna
editing complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021376350A
Other languages
English (en)
Other versions
AU2021376350A9 (en
Inventor
Wei Chen
Junhong CHOI
Jay Ashok Shendure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of AU2021376350A1 publication Critical patent/AU2021376350A1/en
Publication of AU2021376350A9 publication Critical patent/AU2021376350A9/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AU2021376350A 2020-11-05 2021-11-04 Precise genome deletion and replacement method based on prime editing Abandoned AU2021376350A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063110304P 2020-11-05 2020-11-05
US63/110,304 2020-11-05
PCT/US2021/058079 WO2022098885A1 (en) 2020-11-05 2021-11-04 Precise genome deletion and replacement method based on prime editing

Publications (2)

Publication Number Publication Date
AU2021376350A1 true AU2021376350A1 (en) 2023-06-22
AU2021376350A9 AU2021376350A9 (en) 2024-06-13

Family

ID=81458283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021376350A Abandoned AU2021376350A1 (en) 2020-11-05 2021-11-04 Precise genome deletion and replacement method based on prime editing

Country Status (6)

Country Link
US (1) US20240011055A1 (https=)
EP (1) EP4240840A4 (https=)
JP (1) JP2023549125A (https=)
CN (1) CN116829706A (https=)
AU (1) AU2021376350A1 (https=)
WO (1) WO2022098885A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4232583A1 (en) 2020-10-21 2023-08-30 Massachusetts Institute of Technology Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
US20250354177A1 (en) * 2022-05-30 2025-11-20 Wuhan University System and methods for duplicating target fragments
WO2024233655A1 (en) * 2023-05-08 2024-11-14 Prime Medicine, Inc. Genome editing compositions and methods for treatment of fragile x syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3472321A2 (en) * 2016-06-17 2019-04-24 Genesis Technologies Limited Crispr-cas system, materials and methods
WO2020191233A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
EP4085141A4 (en) * 2019-12-30 2024-03-06 The Broad Institute, Inc. GENOME EDITING USING REVERSE TRANSCRIPTASE FOR FULLY ACTIVE CRISPR COMPLEXES
IL297761A (en) * 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence

Also Published As

Publication number Publication date
WO2022098885A1 (en) 2022-05-12
US20240011055A1 (en) 2024-01-11
EP4240840A1 (en) 2023-09-13
JP2023549125A (ja) 2023-11-22
CN116829706A (zh) 2023-09-29
AU2021376350A9 (en) 2024-06-13
EP4240840A4 (en) 2025-01-01

Similar Documents

Publication Publication Date Title
Tao et al. Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
Tao et al. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
US11512325B2 (en) RNA-guided human genome engineering
Xie et al. High-fidelity SaCas9 identified by directional screening in human cells
US20200299767A1 (en) Compositions and methods for accurately identifying mutations
Mefferd et al. Expression of CRISPR/Cas single guide RNAs using small tRNA promoters
WO2017181107A2 (en) Modified cpf1 mrna, modified guide rna, and uses thereof
US20240011055A1 (en) Precise genome deletion and replacement method based on prime editing
Zhang et al. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
CN116194593A (zh) 被称为“CTL-seq”(CRISPR Tag Linear-seq)的核酸酶中靶/脱靶编辑位点的提名方法
Liu et al. LM-PCR permits highly representative whole genome amplification of DNA isolated from small number of cells and paraffin-embedded tumor tissue sections
WO2022197727A1 (en) Generation of novel crispr genome editing agents using combinatorial chemistry
Thulson Long Range Gene Regulation in Human Health and Disease
HK40116830A (en) Rna-guided human genome engineering
WO2024138131A1 (en) Expanding applications of zgtc alphabet in protein expression and gene editing
WO2026071097A1 (ja) ステムループ型アダプター，ｇＲＮＡ作製用ポリヌクレオチドライブラリー，及びそれらの利用方法
HK40103974A (en) Rna-guided human genome engineering
HK40014881B (en) Rna-guided human genome engineering
Kleinstiver et al. Genome-wide specificity profiles of CRISPR-Cas Cpf1 nucleases in human cells
Scott Interrogation of CRISPR-Cas targeting specificity for mammalian genome engineering

Legal Events

Date Code Title Description
SREP Specification republished
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period